Navigation Links
Extra hormone found to cut appetite by a third

Studies done previously have shown that the hormone could suppress the appetites of lean people. But researchers were worried it would not work in obese people because studies of another appetite-suppressing hormone,// leptin, had proved disappointing.

"We had to do a second trial to see if obese people were as sensitive" to the hormone, said researchers. The answer: "Yes, they are. They're just as sensitive as thin people."

In a small study done , both obese and lean people ate about 30 percent less from a buffet lunch after they were given a dose of the hormone, PYY3-36, to trick the brain into thinking they had already eaten. The research also showed lower natural levels of PYY in the obese, which may explain why they are hungrier and overeat.

However researchers say long-term use of the hormone would have to be studied before it could be developed into a treatment for obesity that would consist of injections given before meals. "We haven't yet shown you get actual weight reduction. We've only shown you eat less," researchers said.

The findings could also point to a more natural treatment for obesity: A high-fiber diet is believed to boost the body's production of PYY.

The PYY hormone, one of a number of hormones that stimulate or suppress hunger, is released by the gut as you eat. It tells the part of the brain that controls appetite when you are full. Dr. Rudolph L. Leibel, an obesity researcher , said it is unlikely that PYY alone will turn out to be the "magic bullet" against obesity, but it may prove useful in combination with other drugs. He said the body has backup systems that kick in to resist the loss of body fat -- the reason so many people who lose weight gain it back.

"We can't fool Mother Nature yet," he said. Currently, there are only a few prescription weight-control drugs, and they produce only modest weight loss. They work by suppressing the appetite through a brain chemical or by blockin g fat from being absorbed.

The British researchers recruited 24 people: 12 obese and 12 lean. Their food consumption was monitored twice, once after an intravenous dose of synthetic PYY and once after getting a harmless saline solution. Two hours later, they were given a large buffet lunch.

After the PYY dose, the obese ate 30 percent fewer calories than they did after the dummy solution. The lean people ate 31 percent less. The PYY continued to curb their appetites for 12 hours, with the obese eating 26 percent less and the lean eating about 34 percent less, based on food diaries they kept.

The PYY did not affect food consumption from 12 hours to 24 hours after the infusion. Without the extra dose, PYY levels were lower in the obese participants than in the lean, but the researchers said it is not known whether that is a cause of obesity or a consequence.

If it's a consequence of obesity, it would explain why once people become overweight, it is very difficult for them to reverse it. They don't feel as feel as full after food as normal people do as a result of their obesity.

Related medicine news :

1. Is Drinking Extra Fluids Safe When You’re Sick
2. Extracts of grapefruit heals stomach ulcers
3. Yet Another Use For Green Tea Extract
4. Tomato Extract Found To Reduce The Risk Of Thrombosis
5. Slowing Cartilage Loss In Arthritis With Fruit Extracts
6. Extravagant Pay For Emergency Department Head Of Caboolture Hospital
7. High Blood Pressure Can Be Treated With Grape Seed Extract
8. Saw Palmetto Extract No Good In Improving Prostate Health
9. Greenpeace Says 93,000 Extra Cancer Deaths Due To Chernobyl Fallout
10. NHS To Take Extra Care Of The Aged
11. Western Australian Government Spending Extra For Mental Health Services
Post Your Comments:

(Date:11/30/2015)... ... November 30, 2015 , ... ... additions to its industry-leading suite of automated breast density assessment and enterprise ... (RSNA) meeting, November 29-December 4, 2015 (South Hall booth #2377). Volpara’s quantitative ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... Kreithen”), one of the leading plastic surgery practices in Florida, is proud to ... to consult for surgical innovations giant Ethicon Inc., a Johnson & Johnson Company. ...
(Date:11/30/2015)... ... 30, 2015 , ... The successful filing of an Investigational New Drug application ... important to this key industry segment, Regis Technologies has decided to sponsor and participate ... at 11am EST. , Federal law does not allow new drugs to cross state ...
(Date:11/30/2015)... , ... November 30, 2015 , ... ... assets of DataTrade Solutions Inc., a Healthcare IT consulting, development and support company. ... programming and technical experience available within DataTrade to extend the services currently provided ...
(Date:11/30/2015)... ... November 30, 2015 , ... GKhair & Tibolli team members and ... Beauty Show held on November 8th and 9th at the Puerto Rico Convention Center, ... artists, renowned beauticians and top of the line fashion journalists. The San Juan Beauty ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... 30, 2015 Cumberland Pharmaceuticals (CPIX), today announced that ... on December 3, 2015. TIME: 3:15p.m. ET ... ET LINK: --> DATE: ... --> --> ... are invited to ask the company questions in real-time - ...
(Date:11/30/2015)... -- Varian Medical Systems (NYSE: VAR ) has signed a ... Hospitals Group, the largest hospital chain in India ... in the country. The MoU was signed by Dr. K. ... Kakkar , Varian,s India managing director, in ... , Varian intends to deploy its Access to Care program by ...
(Date:11/30/2015)... and BOSTON , November 30, 2015 ... develop potential new medicines directed at up to 10 ... --> PFE ) to research and develop ... protein-coupled receptor (GPCR) targets across multiple therapeutic areas. ... drug discovery and development company and wholly-owned subsidiary of ...
Breaking Medicine Technology: